iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, will present a corporate overview at the Canaccord Genuity MedTech & Diagnostics Forum, taking place Thursday, November 21st in New York City.
November 18, 2019
· 1 min read